Zai Lab LtdNASDAQ:ZLAB
No Matches were found for
- LAST PRICE18.6900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots18.2000/ 1
- Ask / Lots19.8900/ 1
- Open / Previous Close0.0000 / 18.6900
- Day Range---
- 52 Week Range
- Volume7
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Select an index
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ZLAB |
|---|---|---|
| 09:32 ET | 5102 | 19.245 |
| 09:34 ET | 1178 | 19.1 |
| 09:36 ET | 2356 | 19.21 |
| 09:38 ET | 532 | 19.315 |
| 09:39 ET | 700 | 19.13 |
| 09:41 ET | 3510 | 18.99 |
| 09:43 ET | 200 | 19 |
| 09:45 ET | 400 | 19.02 |
| 09:48 ET | 568 | 18.97 |
| 09:50 ET | 500 | 19.03 |
| 09:54 ET | 200 | 19 |
| 09:59 ET | 400 | 18.8712 |
| 10:01 ET | 4400 | 18.8993 |
| 10:03 ET | 1500 | 18.8692 |
| 10:06 ET | 9343 | 18.78 |
| 10:08 ET | 2603 | 18.77 |
| 10:10 ET | 250 | 18.76 |
| 10:14 ET | 300 | 18.725 |
| 10:15 ET | 2133 | 18.81 |
| 10:17 ET | 100 | 18.82 |
| 10:19 ET | 100 | 18.8 |
| 10:21 ET | 100 | 18.8 |
| 10:24 ET | 225 | 18.79 |
| 10:26 ET | 1200 | 18.88 |
| 10:28 ET | 100 | 18.88 |
| 10:32 ET | 100 | 18.835 |
| 10:33 ET | 100 | 18.8 |
| 10:35 ET | 200 | 18.755 |
| 10:37 ET | 2111 | 18.66 |
| 10:42 ET | 400 | 18.665 |
| 10:44 ET | 420 | 18.665 |
| 10:46 ET | 100 | 18.675 |
| 10:48 ET | 4600 | 18.71 |
| 10:50 ET | 2029 | 18.85 |
| 10:53 ET | 1300 | 18.83 |
| 10:55 ET | 300 | 18.83 |
| 10:57 ET | 1455 | 18.9 |
| 11:00 ET | 1622 | 18.97 |
| 11:04 ET | 410 | 19.017 |
| 11:06 ET | 100 | 19.005 |
| 11:08 ET | 100 | 18.97 |
| 11:09 ET | 600 | 18.985 |
| 11:11 ET | 400 | 19.017 |
| 11:13 ET | 4585 | 19.03 |
| 11:15 ET | 624 | 19.03 |
| 11:18 ET | 200 | 19.025 |
| 11:20 ET | 1200 | 18.915 |
| 11:24 ET | 5705 | 18.875 |
| 11:26 ET | 400 | 18.9 |
| 11:31 ET | 100 | 18.9 |
| 11:36 ET | 100 | 18.9 |
| 11:38 ET | 200 | 18.935 |
| 11:40 ET | 200 | 18.94 |
| 11:44 ET | 100 | 18.935 |
| 11:45 ET | 800 | 18.88 |
| 11:47 ET | 947 | 18.895 |
| 11:49 ET | 100 | 18.92 |
| 11:54 ET | 200 | 18.94 |
| 11:58 ET | 200 | 18.83 |
| 12:00 ET | 200 | 18.83 |
| 12:02 ET | 413 | 18.79 |
| 12:03 ET | 100 | 18.76 |
| 12:05 ET | 100 | 18.78 |
| 12:07 ET | 100 | 18.78 |
| 12:09 ET | 100 | 18.74 |
| 12:12 ET | 100 | 18.72 |
| 12:14 ET | 1000 | 18.71 |
| 12:16 ET | 412 | 18.715 |
| 12:20 ET | 300 | 18.71 |
| 12:21 ET | 300 | 18.67 |
| 12:23 ET | 100 | 18.73 |
| 12:25 ET | 200 | 18.7 |
| 12:27 ET | 1400 | 18.68 |
| 12:30 ET | 200 | 18.685 |
| 12:32 ET | 600 | 18.69 |
| 12:34 ET | 686 | 18.7 |
| 12:36 ET | 7612 | 18.645 |
| 12:38 ET | 985 | 18.67 |
| 12:39 ET | 1100 | 18.74 |
| 12:43 ET | 100 | 18.735 |
| 12:45 ET | 1550 | 18.71 |
| 12:50 ET | 300 | 18.725 |
| 12:52 ET | 200 | 18.71 |
| 12:54 ET | 100 | 18.715 |
| 12:56 ET | 150 | 18.74 |
| 12:57 ET | 500 | 18.695 |
| 12:59 ET | 500 | 18.685 |
| 01:01 ET | 200 | 18.66 |
| 01:06 ET | 700 | 18.63 |
| 01:08 ET | 500 | 18.69 |
| 01:10 ET | 100 | 18.675 |
| 01:12 ET | 607 | 18.71 |
| 01:15 ET | 500 | 18.65 |
| 01:17 ET | 105 | 18.675 |
| 01:19 ET | 100 | 18.65 |
| 01:21 ET | 1400 | 18.65 |
| 01:26 ET | 534 | 18.625 |
| 01:28 ET | 600 | 18.655 |
| 01:30 ET | 100 | 18.6225 |
| 01:32 ET | 600 | 18.65 |
| 01:33 ET | 300 | 18.62 |
| 01:35 ET | 500 | 18.62 |
| 01:37 ET | 750 | 18.63 |
| 01:39 ET | 1100 | 18.62 |
| 01:42 ET | 1105 | 18.61 |
| 01:44 ET | 1300 | 18.65 |
| 01:46 ET | 674 | 18.67 |
| 01:48 ET | 100 | 18.7 |
| 01:50 ET | 400 | 18.63 |
| 01:51 ET | 1000 | 18.6425 |
| 01:53 ET | 1000 | 18.635 |
| 01:55 ET | 495 | 18.66 |
| 01:57 ET | 200 | 18.6 |
| 02:00 ET | 500 | 18.6 |
| 02:02 ET | 297 | 18.58 |
| 02:04 ET | 400 | 18.58 |
| 02:06 ET | 300 | 18.61 |
| 02:08 ET | 311 | 18.63 |
| 02:09 ET | 713 | 18.59 |
| 02:11 ET | 300 | 18.645 |
| 02:13 ET | 100 | 18.66 |
| 02:15 ET | 300 | 18.62 |
| 02:20 ET | 786 | 18.63 |
| 02:22 ET | 100 | 18.66 |
| 02:24 ET | 300 | 18.615 |
| 02:26 ET | 100 | 18.63 |
| 02:27 ET | 200 | 18.635 |
| 02:29 ET | 600 | 18.595 |
| 02:31 ET | 1337 | 18.61 |
| 02:33 ET | 650 | 18.64 |
| 02:36 ET | 200 | 18.62 |
| 02:38 ET | 2400 | 18.62 |
| 02:40 ET | 1568 | 18.55 |
| 02:42 ET | 100 | 18.5725 |
| 02:44 ET | 5200 | 18.575 |
| 02:45 ET | 500 | 18.61 |
| 02:47 ET | 600 | 18.61 |
| 02:51 ET | 1000 | 18.575 |
| 02:54 ET | 500 | 18.575 |
| 02:56 ET | 1300 | 18.62 |
| 02:58 ET | 300 | 18.62 |
| 03:00 ET | 700 | 18.63 |
| 03:03 ET | 900 | 18.665 |
| 03:05 ET | 500 | 18.655 |
| 03:07 ET | 200 | 18.6525 |
| 03:09 ET | 600 | 18.635 |
| 03:12 ET | 900 | 18.67 |
| 03:14 ET | 200 | 18.6525 |
| 03:18 ET | 2112 | 18.68 |
| 03:20 ET | 300 | 18.67 |
| 03:21 ET | 100 | 18.63 |
| 03:25 ET | 674 | 18.6 |
| 03:27 ET | 300 | 18.58 |
| 03:30 ET | 947 | 18.565 |
| 03:32 ET | 100 | 18.56 |
| 03:34 ET | 300 | 18.56 |
| 03:36 ET | 1942 | 18.61 |
| 03:38 ET | 1334 | 18.63 |
| 03:39 ET | 1115 | 18.62 |
| 03:41 ET | 950 | 18.64 |
| 03:43 ET | 426 | 18.62 |
| 03:45 ET | 2140 | 18.5901 |
| 03:48 ET | 2482 | 18.605 |
| 03:50 ET | 1684 | 18.55 |
| 03:52 ET | 2334 | 18.57 |
| 03:54 ET | 2616 | 18.57 |
| 03:56 ET | 5485 | 18.61 |
| 03:57 ET | 3636 | 18.61 |
| 03:59 ET | 9994 | 18.69 |
Jun 11, 2024
May 22, 2024
Zai Lab Initiates Global Phase 2 Clinical Trial Evaluating ZL-1102 As a Topical Treatment for Chronic Plaque Psoriasis, from 7:30AM ET on Wednesday May 22, 2024 by Dow Jones
7:30AM ET on Wednesday May 22, 2024 by Dow Jones
May 20, 2024
Zai Lab and Innoviva Specialty Therapeutics Announce NMPA Approval for XACDURO(R) (Sulbactam-Durlobactam or SUL-DUR) for Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Acinetobacter Baumannii-Calcoaceticus Complex in China, from 12:21AM ET on Monday May 20, 2024 by Dow Jones
12:21AM ET on Monday May 20, 2024 by Dow Jones*DJ Zai Lab And Innoviva Specialty Therapeutics Announce NMPA Approval For XACDURO(R) (Sulbactam-Durlobactam Or SUL-DUR) For Hospital-Acquired And Ventilator-Associated Pneumonia Caused By Acinetobacter Baumannii-Calcoaceticus Complex In China >ZLAB, from 12:21AM ET on Monday May 20, 2024 by Dow Jones
12:21AM ET on Monday May 20, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Zai Lab Ltd | 1.9B | -5.3x | --- |
Maravai LifeSciences Holdings Inc | 1.9B | -7.6x | --- |
Galapagos NV | 1.7B | 51.0x | --- |
Kiniksa Pharmaceuticals Ltd | 1.3B | 220.3x | --- |
Dynavax Technologies Corp | 1.5B | 231.2x | --- |
Vericel Corp | 2.1B | 4,423.6x | --- |
Company Information
Zai Lab Ltd is a holding company mainly engaged in the biopharmaceutical field. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including oncology, autoimmune and infectious diseases fields. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include Niraparib (ZL-2306), ZL-2103, ZL-1101 and others.
Contact Information
- Headquarters
- 4560 Jinke Road, Bldg. 1, 4/F, PudongSHANGHAI, SHA, China 201210
- Phone
- 216-163-2588
- Fax
- 216-163-2570
Executives
- Chairman of the Board, Chief Executive Officer, Co-Founder
- Du Ying
- President, Chief Operating Officer
- Joshua Smiley
- Chief Financial Officer
- Yajing Chen
- President, Head of Global Research and Development
- Rafael Amado
- President, Head - Global Development of Neuroscience, Autoimmune and Infectious Diseases
- Harald Reinhart
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.9B |
|---|---|
Revenue (TTM) | $291.1M |
Shares Outstanding | 99.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.06 |
EPS | $-3.50 |
Book Value | $8.19 |
P/E Ratio | -5.3x |
Price/Sales (TTM) | 6.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -126.21% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
